About Censa Pharmaceuticals

Censa Pharmaceuticals is a late-stage pharmaceutical company developing CNSA-001 for the treatment of phenylketonuria (PKU) and other diseases associated with defects in the tetrahydrobiopterin biochemical pathways.

LEADERSHIP

INVESTORS